Correlation Between Tempest Therapeutics and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and CytomX Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and CytomX Therapeutics.
Diversification Opportunities for Tempest Therapeutics and CytomX Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Tempest and CytomX is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and CytomX Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 1.28 times more return on investment than CytomX Therapeutics. However, Tempest Therapeutics is 1.28 times more volatile than CytomX Therapeutics. It trades about -0.12 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 108.00 in Tempest Therapeutics on August 24, 2024 and sell it today you would lose (15.83) from holding Tempest Therapeutics or give up 14.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tempest Therapeutics vs. CytomX Therapeutics
Performance |
| Timeline |
| Tempest Therapeutics |
| CytomX Therapeutics |
Tempest Therapeutics and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and CytomX Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
| CytomX Therapeutics vs. Lyra Therapeutics | CytomX Therapeutics vs. Hookipa Pharma | CytomX Therapeutics vs. Cingulate Warrants | CytomX Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |